Covered recipient · General Payments record
BRITTANY DEE MUELLER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$981.73
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $381.35 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $85.97 | 5 |
| Amgen Inc. | $80.51 | 1 |
| Lilly USA, LLC | $79.45 | 5 |
| Exact Sciences Corporation | $58.91 | 3 |
| GlaxoSmithKline, LLC. | $30.63 | 2 |
| PFIZER INC. | $29.81 | 2 |
| Currax Pharmaceuticals LLC | $16.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $80.51 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111657177 | CMS |
| Currax Pharmaceuticals LLC | $16.07 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089509568 | CMS |
| Exact Sciences Corporation | $22.51 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114799405 | CMS |
| Exact Sciences Corporation | $13.82 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114799410 | CMS |
| Exact Sciences Corporation | $22.58 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114799416 | CMS |
| GlaxoSmithKline, LLC. | $14.75 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116468842 | CMS |
| GlaxoSmithKline, LLC. | $15.88 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116580539 | CMS |
| Lilly USA, LLC | $13.64 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136079569 | CMS |
| Lilly USA, LLC | $14.98 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136080143 | CMS |
| Lilly USA, LLC | $17.33 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136090418 | CMS |
| Lilly USA, LLC | $19.25 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083820 | CMS |
| Lilly USA, LLC | $14.25 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136079571 | CMS |
| Novo Nordisk Inc | $14.93 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096889514 | CMS |
| Novo Nordisk Inc | $19.55 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096714895 | CMS |
| Novo Nordisk Inc | $17.83 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096580415 | CMS |
| Novo Nordisk Inc | $17.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097377305 | CMS |
| Novo Nordisk Inc | $15.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096643141 | CMS |
| PFIZER INC. | $14.69 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131839428 | CMS |
| PFIZER INC. | $15.12 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131907441 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.